| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 5, 2026 | ±2.8% | +1.9% | over-priced |
| October 29, 2025 | ±1.6% | -2.4% | under-priced |
| August 5, 2025 | ±2.7% | +0.7% | over-priced |
| May 12, 2025 | ±1.8% | +0.5% | over-priced |
| October 29, 2024 | ±2.2% | +0.8% | over-priced |
| August 6, 2024 | ±3.2% | +1.2% | over-priced |
| May 2, 2024 | ±2.5% | +1.8% | over-priced |
| November 7, 2023 | ±2.3% | +1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.87 | $3.4B | $275M |
| Q4 FY2025 | $3.22 | $3.6B | $331M |
| Q3 FY2025 | $2.04 | $3.4B | $240M |
| Q2 FY2025 | $2.58 | $3.4B | $275M |
DaVita Inc. (DVA) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced DVA's earnings risk. Fundamentals into the print: EPS up 43.5% year-over-year, revenue up 6.0%. QuantLogix's live 5-factor engine currently reads DVA as a buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →